An observational study in Radiation Toxicity, sponsored by Essentia Health. Completed at 1 site in United States. Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-11-15.
Sponsored by Essentia Health · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 81 studies in Radiation Injuries with a site in United States — 10 open to participants now, 12 under way, none of them phase 3. Radiation Injuries · United States.
Among the 81 studies in Radiation Injuries with a site in United States, this one is the 13th largest by enrollment of the 15 observational ones that give a count, is one of 5 that started in 2008, is one of 15 observational ones, and was the 44th registered.
328 studies on the registry are indexed under Radiation Injuries; 96 are open to participants now.
Browse Radiation Injuries studies →10 of the 81 studies in Radiation Injuries with a site in United States are open now. Recruiting first, the newest first:
Indiana University · Sites in United States
Ages 18+
UNCANCER LLC · Sites in United States
Ages 18+
University of Cincinnati · Sites in United States
Ages 18+
University of Chicago · Sites in United States
Ages 18+
University of Rochester · Sites in United States
Ages 18–70 · Men only
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 76 Radiation Injuries studies recruiting now, 52 (68%) set no upper age limit and 14 (18%) stop at 75 or younger; 8 take children under 18; 2 take healthy volunteers.
This study: 18 Years and older · female · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
81 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 13 · Phase 2 29 · Phase 3 17
First in 1993; this study’s year is marked. 5 started in 2008.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 20 is below the median of 130 across 96 observational studies indexed under Radiation Injuries.
Median enrollment 47 across the 58 interventional studies, 83 across the 15 observational. Of the 64 that completed or were terminated, 27 (42%) have results posted.
This tab as a report to print or save as PDF → With an account.
3 of 81 have an industry lead sponsor. The 10 most frequent:
Essentia Health is the lead sponsor of 19 studies on the registry; none are open to participants now.
Essentia Health has 1 study filed under Radiation Injuries — fewer than ten, so there is no comparison to draw.
6 of the studies in Radiation Injuries with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04305613Abramson Cancer Center at Penn MedicineCardiotoxicity in Locally Advanced Lung Cancer Patients Treated With Chemoradiation Therapy | 2026-12 |
| NCT04700527UNC Lineberger Comprehensive Cancer CenterThe Effects of SCFA Supplementation in Subjects Receiving Abdominopelvic RT: A Randomized Controlled Study | 2027-04-21 |
| NCT07761910Indiana UniversityProspective Study on Radiation Induced Cardiotoxicity Assessed By PET-CT for Locally Advanced Non-Small Cell Lung Cancer (NSCLC) | 2027-07 |
| NCT06059586Indiana UniversityPre-Rehabilitation for Female Patients Undergoing Pelvic Radiotherapy | 2027-07 |
| NCT07885033UNCANCER LLCOral Care Program for Mouth Side Effects During Head and Neck Radiation Therapy | 2027-08 |
Add all 6 to your calendar (.ics) → With an account.
Among the 81 studies in Radiation Injuries with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study involves women who have had a diagnosis of breast cancer, and have had a lumpectomy with radiation treatments completed in the past year.
The study will determine the level of oxygen in the skin of the breast that has been radiated, compared with the normal skin of the opposite breast.
The purpose of this study is to determine if there is a decrease in oxygen levels in the skin which has been radiated, hopefully to find a treatment to limit skin damage caused by radiation treatments, for women with breast cancer in the future.
Successful completion of this study will provide data on changes in oxygenation in irradiated tissues. If changes are documented, this study would provide evidence supporting current models of tissue injury following radiotherapy. In addition, these data may provide a mechanistic rationale for clinical approaches to ameliorate the toxicities of radiotherapy. Finally, if a correlation exists between tissue oxygenation and toxicity, the rapid and simple tissue oxygenation test may provide a quantitative measure of toxicity and allow earlier and more precise assessment of both toxicity and efficacy of ameliorative therapies.
Patients who have undergone breast conserving therapy consisting of lumpectomy and pPatients with breast cancer who received postoperative radiotherapy for breast conservation will be identified from tumor registry data and recruited into the study if they have completed radiotherapy less than one year ostoperative radiotherapy.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Cancer (malignancy)
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Tissue Oxygenation
Transcutaneous oxygen detector is used to measure the partial pressure of oxygen. The unit detects electrolytes ionized by oxygen. The measuring electrode also heats the skin being measured to facilitate maximal bloodflow to the area.
Time frame: One visit for 20 minutes
Skin and Soft Tissue Toxicity Will be Assessed Using the RTOG/EORTC Late Radiation Morbidity Scoring Schema When Oxygenation is Measured.
Time frame: One visit
| Milestone | Subjects |
|---|---|
| Started | 20 |
| Completed | 20 |
| Not completed | 0 |
Transcutaneous oxygen detector is used to measure the partial pressure of oxygen. The unit detects electrolytes ionized by oxygen. The measuring electrode also heats the skin being measured to facilitate maximal bloodflow to the area.
| mmHg | Subjects |
|---|---|
| Tissue Oxygenation | 62.5 ± 18.4 |
| Participants | Subjects |
|---|---|
| late subcutaneous toxicitiy score 1 | 19 |
| late subcutaneous toxcity score 2 | 1 |
| late skin toxicity score 1 | 19 |
| late skin toxicity score 2 | 1 |
Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Subjects | — | 0/20 (0%) | 0/20 (0%) |
| Age, Categorical(Participants) | Subjects |
|---|---|
| <=18 years | 0 |
| Between 18 and 65 years | 18 |
| >=65 years | 2 |
| Age, Continuous(years) | Subjects |
|---|---|
| Mean | 63 (41 to 82) |
| Sex: Female, Male(Participants) | Subjects |
|---|---|
| Female | 20 |
| Male | 0 |
| Region of Enrollment(participants) | Subjects |
|---|---|
| United States | 20 |
| tissue oxygenation of nontreated breast(mmHg) | Subjects |
|---|---|
| Mean | 66.3 ± 22.8 |
Plan to share: Yes — publication
The record gives a start of Apr 2008, a primary completion of Jan 2009 and a completion of Aug 2009. It does not say whether these dates are actual or estimated.
Results were first posted in Jun 2018, 9 years 5 months after primary completion.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in May 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Essentia Health